Results 1 to 10 of about 16,111 (225)
Comparative evaluation of enzyme and biocidal activity of Candida auris and Candida albicans
Журнал микробиологии, эпидемиологии и иммунобиологии, 2023 Introduction. Secreted metabolites with enzymatic or toxic properties are important for effecting of Candida spp pathogenicity. The most clinically significant species is C. albicans. However, invasive infections associated with C.
Nadezhda I. Ignatova +5 more
doaj +1 more source
Candida auris: a decade of understanding of an enigmatic pathogenic yeast [PDF]
, 2020 Candida auris is an enigmatic yeast that continues to stimulate interest within the mycology community due its rapid and simultaneous emergence of distinct clades.
Brown, Jason +4 more
core +2 more sources
Indian Journal of Critical Care Medicine, 2022 How to cite this article: Hegde A. Candida auris is Coming. Indian J Crit Care Med 2022;26(5):543-544.
openaire +2 more sources
Journal of Fungi, 2023 Candida auris is an emerging global public health threat and is resistant to most antifungal agents. Though fungi are significant pathogens for animals, the role of C. auris in animal health remains unexplored. Here, we analysed the microbial cultures of skin and ear swabs of 87 dogs in Delhi and performed fungal meta-barcode sequencing of ear and skin
Anamika Yadav +7 more
openaire +3 more sources
Comparison of Two Commercially Available qPCR Kits for the Detection of Candida auris
Journal of Fungi, 2021 Candida auris is an emerging pathogen with resistance to many commonly used antifungal agents. Infections with C. auris require rapid and reliable detection methods to initiate successful medical treatment and contain hospital outbreaks.
Janko Sattler +7 more
doaj +1 more source
Candida auris, what do paediatricians need to know? [PDF]
, 2018 AW is supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of Aberdeen.Peer reviewedPublisher ...
Warris, Adilia
core +1 more source
Cell Viability Assays for Candida auris [PDF]
, 2022 Cell viability assays are useful for assessing the efficacy of antifungal therapeutics and disinfection strategies in vitro. In recent years these assays have been fundamental for the testing of conventional and novel therapies against the nosocomial fungal pathogen Candida auris.
Brown, Jason L. +5 more
openaire +2 more sources
First hospital outbreak of the globally emerging Candida auris in a European hospital [PDF]
, 2016 Background: Candida auris is a globally emerging multidrug resistant fungal pathogen causing nosocomial transmission. We report an ongoing outbreak of C. auris in a London cardio-thoracic center between April 2015 and July 2016.
Abdolrasouli, A +11 more
core +2 more sources
International Journal of Infectious Diseases, 2018 In this case, we report an elderly patient with multiple chronic conditions and prolonged intensive care unit (ICU) stays who had recurrent Candida auris (C. auris) in blood despite antifungal therapy. C.
Adnan Alatoom +6 more
doaj +1 more source
Antibiotics, 2020 Candida auris is an emerging multidrug-resistant fungal pathogen reported worldwide. Infections due to C. auris are usually nosocomial and associated with high rates of fluconazole resistance and mortality.
Mahmoud Ghannoum +11 more
doaj +1 more source